Cargando…
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
BACKGROUND: The efficacy of cholesterol lowering agents, specifically statins, in slowing the rate of decline of cognitive function in Alzheimer’s disease (AD) patients is not yet fully understood. Our team’s previously published paper showed that patients who used statins demonstrated no increase i...
Autores principales: | Crum, Jana, Wilson, Jeffrey, Sabbagh, Marwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169006/ https://www.ncbi.nlm.nih.gov/pubmed/30285877 http://dx.doi.org/10.1186/s13195-018-0430-7 |
Ejemplares similares
-
Clinico‐pathological comparison of patients with autopsy‐confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology
por: Chatterjee, Atri, et al.
Publicado: (2021) -
Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021) -
Plasma sphingolipid changes with autopsy-confirmed Lewy body or Alzheimer's pathology
por: Savica, Rodolfo, et al.
Publicado: (2016) -
Longitudinal naming and repetition relates to AD pathology and burden in autopsy‐confirmed primary progressive aphasia
por: Cousins, Katheryn A.Q., et al.
Publicado: (2021) -
Completed suicide in an autopsy-confirmed case of early onset Alzheimer’s disease
por: Hartzell, Jennifer Wiener, et al.
Publicado: (2018)